James Condulis
Stock Analyst at Stifel
(2.78)
# 1,960
Out of 4,983 analysts
6
Total ratings
80%
Success rate
16.6%
Average return
Main Sectors:
Top Industries:
Stocks Rated by James Condulis
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CYTK Cytokinetics | Maintains: Buy | $87 → $96 | $49.44 | +94.17% | 2 | Sep 2, 2025 | |
| NAMS NewAmsterdam Pharma Company | Initiates: Buy | $44 | $24.12 | +82.42% | 1 | Jun 10, 2025 | |
| SLNO Soleno Therapeutics | Maintains: Buy | $74 → $108 | $51.17 | +111.06% | 2 | Mar 28, 2025 | |
| EWTX Edgewise Therapeutics | Initiates: Hold | $30 | $13.70 | +118.98% | 1 | Jan 22, 2025 |
Cytokinetics
Sep 2, 2025
Maintains: Buy
Price Target: $87 → $96
Current: $49.44
Upside: +94.17%
NewAmsterdam Pharma Company
Jun 10, 2025
Initiates: Buy
Price Target: $44
Current: $24.12
Upside: +82.42%
Soleno Therapeutics
Mar 28, 2025
Maintains: Buy
Price Target: $74 → $108
Current: $51.17
Upside: +111.06%
Edgewise Therapeutics
Jan 22, 2025
Initiates: Hold
Price Target: $30
Current: $13.70
Upside: +118.98%